Personalized Medicine — Predicted 2026

AI-Predicted Question Angles for UPSC 2026

Based on trend analysis, current affairs, and recurring themes in Personalized Medicine.

Personalized Medicine as a tool for equitable healthcare in India: Opportunities and Challenges.

High

This angle combines the aspirational goal of equitable healthcare with the transformative potential of personalized medicine, while acknowledging the significant hurdles. It allows for discussion of government schemes, the digital divide, cost-effectiveness, and ethical access, making it highly relevant for GS-II (Social Justice) and GS-III (Science & Tech, Economy). The 'personalized medicine healthcare accessibility' long-tail keyword is directly addressed here, making it a strong candidate for a Mains question.

The synergistic role of AI and Genomics in accelerating drug discovery and development for rare diseases, with a focus on India's contribution.

Medium to High

This angle focuses on the technological convergence and a specific application area (rare diseases), which often lack effective treatments. It allows for discussion of 'AI machine learning drug discovery' and 'pharmacogenomics applications in drug development' within the Indian context, highlighting indigenous research and startup contributions. This is a strong Science & Technology question for Mains, potentially linking to India's role in global health innovation.

Critically evaluate the regulatory and ethical framework required for the responsible implementation of personalized medicine in India, particularly concerning genetic data privacy.

High

Given the recent enactment of the DPDP Act 2023 and ongoing debates on genetic privacy, this angle is extremely pertinent. It directly addresses 'personalized medicine ethical issues privacy' and 'genetic testing direct consumer regulations'. It allows for a critical analysis of existing laws, ethical guidelines (ICMR), and the need for robust mechanisms to prevent genetic discrimination and ensure informed consent. This is a classic GS-II (Governance) and GS-IV (Ethics) question, demanding a nuanced and well-informed answer.